Login / Register for free to get access to My MedWorm

CefprozilCefprozil RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you your search results in order of date.

40 records returned

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 8, 2009 Category: Allergy & Immunology Source Type: consumer

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 8, 2009 Category: Drugs & Pharmacology Source Type: consumer

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - October 8, 2009 Category: Gastroenterology Source Type: consumer

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Senior Health General)
Source: MedicineNet Senior Health General - October 8, 2009 Category: Geriatrics Source Type: consumer

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Hepatitis C General)
Source: MedicineNet Hepatitis C General - October 8, 2009 Category: Infectious Diseases Source Type: consumer

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - October 8, 2009 Category: OBGYN Source Type: consumer

cefprozil, Cefzilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: cefprozil, CefzilCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 10/8/2009 (Source: MedicineNet Hearing General)
Source: MedicineNet Hearing General - October 8, 2009 Category: Audiology Source Type: consumer

Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibioticsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Conclusions Despite high rates of β-lactamase production among non-typeable H. influenzae and M. catarrhalis, multiple oral treatment options exist for non-typeable H. influenzae and M. catarrhalis. Multidrug-resistant serotype 19A S. pneumoniae (~20%) limits treatment options for ambulatory S. pneumoniae respiratory disease. (Source: Journal of Antimicrobial Chemotherapy)
Source: Journal of Antimicrobial Chemotherapy - February 11, 2009 Category: Microbiology Authors: Harrison, C. J., Woods, C., Stout, G., Martin, B., Selvarangan, R. Tags: Original research Source Type: journals

Probability of Achieving Requisite Pharmacodynamic Exposure for Oral beta-Lactam Regimens against Haemophilus influenzae in Children.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSION: Against H. influenzae, the antibacterials most likely to achieve optimal in vivo exposures in children are cefpodoxime, ceftibuten, and amoxicillin/clavulanic acid. PMID: 18998749 [PubMed - in process] (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 13, 2008 Category: Pediatrics Authors: Pichichero ME, Doern GV, Kuti JL, Nicolau DP Tags: Paediatr Drugs Source Type: journals

Pharmacodynamic Target Attainment of Oral beta-Lactams for the Empiric Treatment of Acute Otitis Media in Children.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSIONS: Based on the recent epidemiologic and resistance profiles of S. pneumoniae and H. influenzae, amoxicillin/clavulanic acid (45 mg/kg every 12 hours) and cefpodoxime (5 mg/kg every 12 hours) provide the greatest likelihood of achieving optimal pharmacodynamic exposures empirically in children with AOM. PMID: 18754699 [PubMed - in process] (Source: Paediatric Drugs)
Source: Paediatric Drugs - August 31, 2008 Category: Pediatrics Authors: Fallon RM, Kuti JL, Doern GV, Girotto JE, Nicolau DP Tags: Paediatr Drugs Source Type: journals

Cefprozil(CEFPROZIL) Tablet, Film Coated [ORCHID HEALTHCARE (A DIVISION OF ORCHID CHEMICALS AND PHARMACEUTICALS LTD.)]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: May 22, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - May 22, 2008 Category: Drugs & Pharmacology Source Type: organizations

Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Among orally administered cephalosporins, aminopenicillins (+/-clavulanate), and macrolides, cefditoren was the most potent agent against Haemophilus influenzae (MIC(50/90), </=0.008/0.03 mug/mL; 316 isolates including 100 beta-lactamase-positive and 10 beta-lactamase-negative ampicillin-resistant [BLNAR]) and was 32-, 64-, and 512-fold more potent than cefdinir, cefuroxime, and cefprozil, respectively. Cefditoren (MIC(50), 0.03 mug/mL) was also >/=32-fold more active against BLNAR phenotypes, although newer macrolides provided complete coverage against these strains. All Moraxella catarrhalis isolates were inhib...
Source: Diagnostic Microbiology and Infectious Disease - March 18, 2008 Category: Microbiology Authors: Biedenbach DJ, Jones RN, Fritsche TR Tags: Diagn Microbiol Infect Dis Source Type: journals

Cefzil(CEFPROZIL) Tablet, Film Coated Cefzil(CEFPROZIL) Powder, For Suspension [Bristol-Myers Squibb]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Mar 5, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - March 5, 2008 Category: Drugs & Pharmacology Source Type: organizations

Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Bacteriological failure with penicillin that has been used widely for years in group A beta hemolytic streptococcal (GABHS) tonsillopharyngitis is being reported as high as 30%. Because of this unresponsiveness, many different agents are being used as alternative options. We evaluated the effect of clarithromycin, amoxicillin/clavulanate (CAM), cefprozil and benzathine penicillin G (Pen G) on the bacteriological cure, beta-lactamase production, pharyngeal microflora and alpha hemolytic streptococci (AHS) when used in the treatment of pediatric GABHS tonsillopharyngitis. Intramuscular Pen G and oral clarithromycin, CAM ...
Source: The Turkish Journal of Pediatrics - March 1, 2008 Category: Pediatrics Authors: Yildirim I, Ceyhan M, Gür D, Kaymakoğlu I Tags: Turk J Pediatr Source Type: journals

Cefprozil(Cefprozil) Tablet, Film Coated [TEVA PHARMACEUTICALS USA]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Feb 27, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 27, 2008 Category: Drugs & Pharmacology Source Type: organizations

Cefprozil(CEFPROZIL) Powder, For Suspension [ORCHID HEALTHCARE (A DIVISION OF ORCHID CHEMICALS AND PHARMACEUTICALS LTD.)]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Feb 27, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 27, 2008 Category: Drugs & Pharmacology Source Type: organizations

Cefprozil(CEFPROZIL) Tablet, Film Coated [ORCHID HEALTHCARE (A DIVISION OF ORCHID CHEMICALS AND PHARMACEUTICALS LTD.)]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Feb 22, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 22, 2008 Category: Drugs & Pharmacology Source Type: organizations

Cefprozil(Cefprozil) Tablet, Film Coated [Lupin Pharmaceuticals, Inc.]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Jan 25, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 25, 2008 Category: Drugs & Pharmacology Source Type: organizations

Cefprozil(CEFPROZIL) Powder, For Suspension [Lupin Pharmaceuticals, Inc.]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Jan 25, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 25, 2008 Category: Drugs & Pharmacology Source Type: organizations

Cefprozil(Cefprozil) Powder, For Suspension [Aurobindo Pharma Limited]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Jan 25, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 25, 2008 Category: Drugs & Pharmacology Source Type: organizations

Redefining the management of pediatric tonsillopharyngitis with Cefprozilemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abstract  Tonsillopharyngitis is very common in children, with Group A Streptococci being the most common bacterial etiology. Effective antibacterial treatment is imperative due to risk of rheumatic fever. Cephalosporins have been used successfully for the treatment of Group A beta-hemolytic Streptococcal (GABHS) tonsillopharyngitis. Cefprozil is a novel broad-spectrum oral cephalosporin. Cefprozil is rapidly absorbed from the gastrointestinal tract with high bioavailability. The excellent penetration of cefprozil into tonsillar and adenoidal tissue corresponds well with the clinical outcome. The drug provide...
Source: Indian Journal of Pediatrics - January 21, 2008 Category: Pediatrics Tags: Indian Journal of Pediatrics Source Type: journals

Cefprozil(Cefprozil) Tablet, Film Coated [Lek Pharmaceuticals Inc.]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Oct 10, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - October 10, 2007 Category: Drugs & Pharmacology Source Type: organizations

A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Conclusions Prevalence of penicillin and macrolide–azalide resistance among S. pneumoniae appears to be on the increase in Turkey while overall ß-lactamase production in H. influenzae remains relatively low. To adequately monitor the spread of drug-resistant phenotypes among these two important CARTI pathogens, ongoing collection of resistance surveillance data is required—where possible locally as resistance patterns can vary substantially between cities and institutions. (Source: Journal of Antimicrobial Chemotherapy)
Source: Journal of Antimicrobial Chemotherapy - August 14, 2007 Category: Microbiology Authors: Sener, B., Tunckanat, F., Ulusoy, S., Tunger, A., Soyletir, G., Mulazimoglu, L., Gurler, N., Oksuz, L., Koksal, I., Aydin, K., Yalcin, A. N., Ogunc, D., Acar, A., Sievers, J. Tags: Original articles Source Type: journals

Cefprozil(Cefprozil) Powder, For Suspension [Aurobindo Pharma Limited]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Jul 6, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - July 6, 2007 Category: Drugs & Pharmacology Source Type: organizations

Cefzil(Cefprozil) Tablet, Film Coated Cefzil(Cefprozil) Powder, For Suspension [Bristol-Myers Squibb]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Updated Date: Jun 29, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 29, 2007 Category: Drugs & Pharmacology Source Type: organizations

Oral cefprozil has good penetration into the middle ear fluid (MEF) of paediatric patients with acute otitis mediaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Inpharma)
Source: Inpharma - April 27, 2007 Category: Drugs & Pharmacology Tags: Research article Source Type: journals

Oral cefprozil has good penetration into the middle ear fluid (MEF) of paediatric patients with acute otitis media.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Page: 23 (Source: Inpharma Weekly)
Source: Inpharma Weekly - April 21, 2007 Category: Drugs & Pharmacology Tags: HTML Source Type: journals

Pharmacokinetics of Cefprozil in Plasma and Middle Ear Fluid: In Children Undergoing Treatment for Acute Otitis Mediaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Pediatric Drugs)
Source: Pediatric Drugs - April 8, 2007 Category: Pediatrics Authors: Nicolau, David P.Sutherland, Christina A.Arguedas, AdrianoDagan, RonPichichero, Micheal E. Tags: Original Research Article Source Type: journals

Pharmacokinetics of Cefprozil in Plasma and Middle Ear Fluid: In Children Undergoing Treatment for Acute Otitis Media.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Page: 119Authors: Nicolau, David P 1; Sutherland, Christina A 1; Arguedas, Adriano 2; Dagan, Ron 3; Pichichero, Micheal E 4 (Source: Pediatric Drugs)
Source: Pediatric Drugs - April 6, 2007 Category: Pediatrics Tags: Abstract HTML PDF (271 K) Source Type: journals

Cefprozil: Hepatitis: case reportemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Reactions)
Source: Reactions - March 7, 2007 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

Cefprozil: Hepatitis: case report.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Reactions Weekly)
Source: Reactions Weekly - March 3, 2007 Category: Drugs & Pharmacology Tags: HTML Source Type: journals

Cefalexin/cefprozil: Fatal hypersensitivity myocarditis (first report with cefprozil) in children: 2 case reportsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Reactions)
Source: Reactions - January 31, 2007 Category: Drugs & Pharmacology Source Type: journals

Cefalexin/cefprozil: Fatal hypersensitivity myocarditis (first report with cefprozil) in children: 2 case reports.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Reactions Weekly)
Source: Reactions Weekly - January 27, 2007 Category: Drugs & Pharmacology Source Type: journals

Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSIONS: The plasma profile of cefprozil in the current analysis is consistent with previously reported values in children receiving the 15 mg/kg twice daily dose. MEF penetration and the duration of drug exposure at the site of infection support the clinical utility of this agent for organisms with minimum inhibitory concentrations (MIC) of < or =1 microg/mL. However, these results also predict higher clinical failure when using this dose of cefprozil against penicillin-non-susceptible Streptococcus pneumoniae or Haemophilus influenzae because of typically higher MIC values for these organisms. PMID: 17407367 [...
Source: Paediatric Drugs - January 1, 2007 Category: Pediatrics Authors: Nicolau DP, Sutherland CA, Arguedas A, Dagan R, Pichichero ME Tags: Paediatr Drugs Source Type: journals

Ranbaxy Is Granted Final Approval To Manufacture And Market Cefprozil Anti- Infective Tabletsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefprozil Tablets USP, 250 mg and 500 mg. The Office of Generic Drugs, U.S. [click link for full article] (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 15, 2006 Category: Consumer Health News Source Type: news

Ranbaxy Is Granted Final Approval To Manufacture And Market Cefprozil Anti- Infective Tabletsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefprozil Tablets USP, 250 mg and 500 mg. The Office of Generic Drugs, U.S. [click link for full article] (Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today)
Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today - December 15, 2006 Category: Infectious Diseases Source Type: news

Ranbaxy Receives Approval To Market Cefprozil Suspensionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Ranbaxy Pharmaceuticals Inc.(RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),announced today that RLL has received approval from the U.S. Food and DrugAdministration to manufacture and market Cefprozil for Oral Suspension USP,125 mg/5mL and 250 mg/5mL. The Office of Generic Drugs, U.S. [click link for full article] (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2006 Category: Consumer Health News Source Type: news

Ranbaxy Receives Approval to Market Cefprozil Suspensionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRINCETON, N.J., June 30 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefprozil for Oral Suspension USP, 125 mg/5mL and 250 mg/5mL. The Office of... (Source: Drug Newswire)
Source: Drug Newswire - July 1, 2006 Category: Pharmaceuticals Source Type: news

Cefprozil (Cefzil) discontinuedemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
For commercial reasons, cefprozil (Cefzil) has been discontinued by Bristol-Myers-Squibb. For further information, please call medical information on 0800 731 1736. (Source: NeLM Headline News)
Source: NeLM Headline News - June 21, 2006 Category: Drugs & Pharmacology Source Type: organizations

Lupin Receives US FDA Approval for Cefprozil Tabletsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MUMBAI, India - Lupin Ltd. today announced that it has received US FDA approval for its Abbreviated New Drug Application (ANDA) for Cefprozil Tablets USP, 250 mg and 500 mg. Cefprozil is the generic equivalent of Bristol-Myers Squibb's Cefzil(R). The tablet market in the US is USD 117 million as... (Source: Drug Newswire)
Source: Drug Newswire - May 20, 2006 Category: Pharmaceuticals Source Type: news